Notes argued from evidence
Insights
Research notes and analysis on innovation, markets, and regulation. Written by our analysts, argued from evidence.
GLP-1 Booster Supplements: Real Science or Borrowed Hype?
What every Indian manufacturer needs to understand before entering the GLP-1 supplement market: the science, the regulatory line, and where the two diverge.
Green Tea: Booming in India, Restricted in Europe
The same green tea extract capsule can carry a weight-management claim in India and be barred from that claim in Europe. That gap is a compliance risk the moment you cross a border.
Switching to Recyclable Food-Contact Plastic? Think, Then Decide.
Sustainable packaging and safe packaging are not the same thing. The gap between the two is exactly where regulatory risk lives.